Track 01 of 14
Interventional Cardiology
TAVR, complex PCI, structural heart and tricuspid/mitral interventions.
Interventional cardiology in 2027 spans low-risk and bicuspid TAVR, transcatheter mitral and tricuspid edge-to-edge repair (TriClip, PASCAL, MitraClip), and a maturing valve-in-valve and valve-in-MAC ecosystem. Coronary work is increasingly imaging- and physiology-guided, with OCT- and IVUS-driven PCI now backed by ILUMIEN IV and OCTOBER, and STEMI strategy reshaped by COMPLETE-2 multivessel data and the STEMI Door-to-Unload Impella program. Sessions also examine LAA closure after CHAMPION-AF, post-RoPE PFO selection, MINOCA workup, and HI-PEITHO-era catheter-directed pulmonary embolism therapy.
Focus areas
- TAVR in low-risk, bicuspid, and small-annulus anatomy
- Mitral and tricuspid TEER, replacement, and valve-in-MAC
- OCT/IVUS-guided complex and bifurcation PCI (ILUMIEN IV, OCTOBER)
- Coronary physiology: FFR, iFR, QFR and microvascular angina
- LAA closure post-CHAMPION-AF and PFO closure post-RoPE
- Chronic total occlusion: DECISION-CTO, EUROCTO and hybrid crossing algorithms
- Catheter-directed pulmonary embolism therapy (HI-PEITHO)